Tarsus Pharmaceuticals, Inc. (TARS) › Capital ExpendituresTarsus Pharmaceuticals, Inc. (TARS) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $175.0K2020: $456.0K2021: $586.0K2022: $506.0K2023: $1.50M2024: $1.57M2025: $9.86M$9.86M2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$9.86M+529.2%2024$1.57M+4.3%2023$1.50M+196.8%2022$506.0K-13.7%2021$586.0K+28.5%2020$456.0K+160.6%2019$175.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share